Immunoreactivity for sex steroid hormone receptors in pulmonary hamartomas

American Journal of Surgical Pathology

Volumn 30, Issue 7, 2006, Pages 819-827

  Pelosi, Giuseppe ^a,c   Rosai, Juan ^b   Viale, Giuseppe ^a  

^a UNIVERSITY OF MILAN   (Italy)

^b Italian Diagnostic Center   (Italy)

^c EUROPEAN INSTITUTE OF ONCOLOGY   (Italy)

Author keywords

Androgen; Estrogen; Hamartoma; Immunohistochemistry; Lung; Myoepithelial; Progesterone; Receptors

Indexed keywords

ANDROGEN RECEPTOR; CALPONIN; CYTOKERATIN; ESTROGEN RECEPTOR; GLIAL FIBRILLARY ACIDIC PROTEIN; PROGESTERONE RECEPTOR; PROTEIN S 100; SMOOTH MUSCLE ACTIN; STEROID RECEPTOR; VIMENTIN; BIOLOGICAL MARKER;

ARTICLE; CELL DIFFERENTIATION; CELLULAR DISTRIBUTION; CLINICAL ARTICLE; FEMALE; GENOTYPE; HAMARTOMA; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; IMMUNOPHENOTYPING; IMMUNOREACTIVITY; LUNG HAMARTOMA; MALE; MYOEPITHELIUM CELL; PLEOMORPHIC ADENOMA; PROTEIN EXPRESSION; SALIVARY GLAND TUMOR; SPINDLE CELL; TUMOR GROWTH; ADULT; AGED; ENZYME IMMUNOASSAY; LUNG DISEASE; METABOLISM; MIDDLE AGED; PATHOLOGY;

ADULT; AGED; BIOLOGICAL MARKERS; FEMALE; HAMARTOMA; HUMANS; IMMUNOENZYME TECHNIQUES; LUNG DISEASES; MALE; MIDDLE AGED; RECEPTORS, ANDROGEN; RECEPTORS, ESTROGEN; RECEPTORS, PROGESTERONE; RECEPTORS, STEROID;

EID: 33746930275     PISSN: 01475185     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.pas.0000208898.38730.36     Document Type: Article

References (84)

1. Altiner M, Paksoy N, Ozturk H. Large cell carcinoma of the lung with unilateral hamartoma. Pathologica. 1996;88:311-312.
2. Basile A, Gregoris A, Antoci B, et al. Malignant change in a benign pulmonary hamartoma. Thorax. 1989;44:232-233.
3. Cavin E, Masters JH, Moody J. Hamartoma of the lung; report of one malignant and three benign cases. J Thorac Surg. 1958;35:816-820.
4. Cheung CP, Yu S, Wong KB, et al. Expression and functional study of estrogen receptor-related receptors in human prostatic cells and tissues. J Clin Endocrinol Metab. 2005;90:1830-1844.
5. Colditz GA, Rosner BA, Chen WY, et al. Risk factors for breast cancer according to estrogen and progesterone receptor status. J Natl Cancer Inst. 2004;96:218-228.
6. Corrin B. Pathology of the Lungs. London: Churchill Livingstone; 2000.
7. Couse JE, Mahato D, Eddy EM, et al. Molecular mechanism of estrogen action in the male: insights from the estrogen receptor null mice. Reprod Fertil Dev. 2001;13:211-219.
8. Crouch JD, Keagy BA, Starek PJ, et al. A clinical review of patients undergoing resection for pulmonary hamartoma. Am Surg. 1988;54:297-299.
9. Cunha GR, Cooke PS, Kurita T. Role of stromal-epithelial interactions in hormonal responses. Arch Histol Cytol. 2004;67:417-434.
10. Dardick I, Cavell S, Boivin M, et al. Salivary gland myoepithelioma variants. Histological, ultrastructural, and immunocytological features. Virchows Arch A Pathol Anat Histopathol. 1989;416:25-42.
11. Dori S, Trougouboff P, David R, et al. Immunohistochemical evaluation of estrogen and progesterone receptors in adenoid cystic carcinoma of salivary gland origin. Oral Oncol. 2000;36:450-453.
12. Elster EA, Markusic J, Ball R, et al. Primary acinic cell carcinoma of the breast. Am Surg. 2002;68:993-995.
13. Esmaeli B, Harvey JT, Hewlett B. Immunohistochemical evidence for estrogen receptors in meibomian glands. Ophthalmology. 2000;107:180-184.
14. Fan CY, Wang J, Barnes EL. Expression of androgen receptor and prostatic specific markers in salivary duct carcinoma: an immunohistochemical analysis of 13 cases and review of the literature. Am J Surg Pathol. 2000;24:579-586.
15. Fletcher JA, Longtine J, Wallace K, et al. Cytogenetic and histologic findings in 17 pulmonary chondroid hamartomas: evidence for a pathogenetic relationship with lipomas and leiomyomas. Genes Chromosomes Cancer. 1995;12:220-223.
16. Furuse C, Sousa SO, Nunes FD, et al. Myoepithelial cell markers in salivary gland neoplasms. Int J Surg Pathol. 2005;13:57-65.
17. Gadkar-Sable S, Shah C, Rosario G, et al. Progesterone receptors: various forms and functions in reproductive tissues. Front Biosci. 2005;10:2118-2130.
18. Gao X, Loggie BW, Nawaz Z. The roles of sex steroid receptor coregulators in cancer. Mol Cancer. 2002;1:7.
19. Glas AS, Hollema H, Nap RE, et al. Expression of estrogen receptor, progesterone receptor, and insulin-like growth factor receptor-1 and of MIB-1 in patients with recurrent pleomorphic adenoma of the parotid gland. Cancer. 2002;94:2211-2216.
20. Gregori-Romero MA, Lopez-Gines C, Cerda-Nicolas M, et al. Recombinations of chromosomal bands 10q24, 12q14-q15, and 14q24 in two cases of pulmonary chondroid hamartoma studied by fluorescence in situ hybridization. Cancer Genet Cytogenet. 2003;142:153-157.
21. Hayward RH, Carabasi RJ. Malignant hamartoma of the lung: fact or fiction? J Thorac Cardiovasc Surg. 1967;53:457-466.
22. Higashita R, Ichikawa S, Ban T, et al. Coexistence of lung cancer and hamartoma. Jpn J Thorac Cardiovasc Surg. 2001;49:258-260.
23. Hoang MP, Callender DL, Sola Gallego JJ, et al. Molecular and biomarker analyses of salivary duct carcinomas: comparison with mammary duct carcinoma. Int J Oncol. 2001;19:865-871.
24. Hornick JL, Fletcher CD. Cutaneous myoepithelioma: a clinicopathologic and immunohistochemical study of 14 cases. Hum Pathol. 2004;35:14-24.
25. Horwitz KB, Mockus MB, Lessey BA. Variant T47D human breast cancer cells with high progesterone-receptor levels despite estrogen and antiestrogen resistance. Cell. 1982;28:633-642.
26. Inoue T, Akahira J, Suzuki T, et al. Progesterone production and actions in the human central nervous system and neurogenic tumors. J Clin Endocrinol Metab. 2002;87:5325-5331.
27. Jeannon JP, Soames JV, Bell H, et al. Immunohistochemical detection of oestrogen and progesterone receptors in salivary tumours. Clin Otolaryngol Allied Sci. 1999;24:52-54.
28. Jin YT, Lian JD, Yan JJ, et al. Pleomorphic adenoma with extensive adipose content. Histopathology. 1996;28:87-89.
29. Karasik A, Modan M, Jacob CO, et al. Increased risk of lung cancer in patients with chondromatous hamartoma. J Thorac Cardiovasc Surg. 1980;80:217-220.
30. Kazmierczak B, Meyer-Bolte K, Tran KH, et al. A high frequency of tumors with rearrangements of genes of the HMGI(Y) family in a series of 191 pulmonary chondroid hamartomas. Genes Chromosomes Cancer. 1999;26:125-133.
31. Kazmierczak B, Rosigkeit J, Wanschura S, et al. HMGI-C rearrangements as the molecular basis for the majority of pulmonary chondroid hamartomas: a survey of 30 tumors. Oncogene. 1996;12:515-521.
32. Kojima R, Mizuguchi M, Bessho F, et al. Pulmonary carcinoma associated with hamartoma in an 11-year-old boy. Am J Pediatr Hematol Oncol. 1993;15:439-442.
33. Konovalov EP, Apostolov VI, Lomteva LF. Squamous cell carcinoma of the lung associated with chondromatous hamartoma. Klin Khir. 1992:62-63.
34. Kuijper A, Buerger H, Simon R, et al. Analysis of the progression of fibroepithelial tumours of the breast by PCR-based clonality assay. J Pathol. 2002;197:575-581.
35. Kumagami H, Onitsuka T. Estradiol and testosterone in minor salivary glands of Sjogren's syndrome. Auris Nasus Larynx. 1993;20:137-143.
36. Leavitt WW, Chen TJ, Allen TC. Regulation of progesterone receptor formation by estrogen action. Ann NY Acad Sci. 1977;286:210-225.
37. Lee PS, Sabbath-Solitare M, Redondo TC, et al. Molecular evidence that the stromal and epithelial cells in pleomorphic adenomas of salivary gland arise from the same origin: clonal analysis using human androgen receptor gene (HUMARA) assay. Hum Pathol. 2000;31:498-503.
38. Maia DM, Sciarrotta J, Abendroth K, et al. Sex steroid receptors in Hodgkin's disease. Leuk Lymphoma. 2000;39:365-371.
39. Malauzat C, Malauzat F, Petit MA, et al. Bronchopulmonary hamartochondroma (apropos of 136 cases, including a homogeneous series of 124 cases). Review of the literature. Rev Pneumol Clin. 1985;41:163-175.
40. Manolagas SC, Kousteni S. Perspective: nonreproductive sites of action of reproductive hormones. Endocrinology. 2001;142:2200-2204.
41. Martins C, Fonseca I, Roque L, et al. PLAG1 gene alterations in salivary gland pleomorphic adenoma and carcinoma ex-pleomorphic adenoma: a combined study using chromosome banding, in situ hybridization and immunocytochemistry. Mod Pathol. 2005;18:1048-1055.
42. Melegari M, Scaglioni PP, Mao GP, et al. Estrogen receptors in the human liver. Medicina (Firenze). 1990;10:154-157.
43. Mentzel T, Requena L, Kaddu S, et al. Cutaneous myoepithelial neoplasms: clinicopathologic and immunohistochemical study of 20 cases suggesting a continuous spectrum ranging from benign mixed tumor of the skin to cutaneous myoepithelioma and myoepithelial carcinoma. J Cutan Pathol. 2003;30:294-302.
44. Money SR, Muss W, Thelmo WL, et al. Immunocytochemical localization of estrogen and progesterone receptors in human thyroid. Surgery. 1989;106:975-978.
45. Moriki T, Ueta S, Takahashi T, et al. Salivary duct carcinoma: cytologic characteristics and application of androgen receptor immunostaining for diagnosis. Cancer. 2001;93:344-350.
46. Nagao T, Gaffey TA, Visscher DW, et al. Invasive micropapillary salivary duct carcinoma: a distinct histologic variant with biologic significance. Am J Surg Pathol. 2004;28:319-326.
47. Nasser SM, Faquin WC, Dayal Y. Expression of androgen, estrogen, and progesterone receptors in salivary gland tumors. Frequent expression of androgen receptor in a subset of malignant salivary gland tumors. Am J Clin Pathol. 2003;119:801-806.
48. Nilsson O, Chrysis D, Pajulo O, et al. Localization of estrogen receptors-alpha and -beta and androgen receptor in the human growth plate at different pubertal stages. J Endocrinol. 2003;177:319-326.
49. Noguchi S, Aihara T, Yoshino K, et al. Demonstration of monoclonal origin of human parotid gland pleomorphic adenoma. Cancer. 1996;77:431-435.
50. Obiditsch-Mayer I, Zeitlhofer J. On malignant hamartoma of the lung. Krebsarzt. 1962;17:102-109.
51. Onitsuka T. Sex hormones in papillary carcinoma of thyroid gland and pleomorphic adenoma of parotid gland. Acta Otolaryngol. 1994;114:218-222.
52. Pelosi G, Bresaola E, Bogina G, et al. Endocrine tumors of the pancreas: Ki-67 immunoreactivity on paraffin sections is an independent predictor for malignancy. A comparative study with PCNA and progesterone receptor protein immunostaining, mitotic index, and other clinicopathologic variables. Hum Pathol. 1996;27:1124-1134.
53. Pelosi G, Maffini F, Decarli N, et al. Progesterone receptor immunoreactivity in minute meningothelioid nodules of the lung. Virchows Arch. 2002;440:543-546.
54. Pelosi G, Rodriguez MDJ, Viale G, et al. Salivary gland-type tumors with myoepithelial differentiation arising in pulmonary hamartoma: report of 2 cases of a hitherto unrecognized association. Am J Surg Pathol. In press.
55. Perez-Atayde AR, Seiler MV. Pulmonary hamartoma: an ultrastructural study. Cancer. 1984;53:485-492.
56. Perry A, Lusis EA, Gutmann DH. Meningothelial hyperplasia: a detailed clinicopathologic, immunohistochemical and genetic study of 11 cases. Brain Pathol. 2005;15:109-115.
57. Pires FR, da Cruz Perez DE, de Almeida OP, et al. Estrogen receptor expression in salivary gland mucoepidermoid carcinoma and adenoid cystic carcinoma. Pathol Oncol Res. 2004;10:166-168.
58. Poulsen JT, Jacobsen M, Francis D. Probable malignant transformation of a pulmonary hamartoma. Thorax. 1979;34:557-558.
59. Rees ML, Marshall I, McIntosh GG, et al. Wild-type estrogen receptor beta expression in normal and neoplastic paraffin-embedded tissues. Hybrid Hybridomics. 2004;23:11-18.
60. Ribet M, Jaillard-Thery S, Nuttens MC. Pulmonary hamartoma and malignancy. J Thorac Cardiovasc Surg. 1994;107:611-614.
61. Riva C, Dainese E, Caprara G, et al. Immunohistochemical study of androgen receptors in breast carcinoma. Evidence of their frequent expression in lobular carcinoma. Virchows Arch. 2005:1-6.
62. Romanelli R, Adamoli S. Adenocarcinoma appearing in a chondromatous hamartoma of the lung. Pathologica. 1968;60:401-407.
63. Sato K, Ueda Y, Shimasaki M, et al. Pleomorphic adenoma (benign mixed tumor) of the breast: a case report and review of the literature. Pathol Res Pract. 2005;201:333-339.
64. Schurch W, Potvin C, Seemayer TA. Malignant myoepithelioma (myoepithelial carcinoma) of the breast: an ultrastructural and immunocytochemical study. Ultrastruct Pathol. 1985;8:1-11.
65. Segen JC, Foo M, Richer S. Pleomorphic adenoma of the breast with positive estrogen receptors. N Y State J Med. 1986;86:265-266.
66. Sgibneva OV. Rare case of malignization of a pulmonary hamartoma. Arkh Patol. 1972;34:78-79.
67. Simpson RH, Pereira EM, Ribeiro AC, et al. Polymorphous lowgrade adenocarcinoma of the salivary glands with transformation to high-grade carcinoma. Histopathology. 2002;41:250-259.
68. Stone FJ, Churg AM. The ultrastructure of pulmonary hamartoma. Cancer. 1977;39:1064-1070.
69. Tallini G, Vanni R, Manfioletti G, et al. HMGI-C and HMGI(Y) immunoreactivity correlates with cytogenetic abnormalities in lipomas, pulmonary chondroid hamartomas, endometrial polyps, and uterine leiomyomas and is compatible with rearrangement of the HMGI-C and HMGI(Y) genes. Lab Invest. 2000;80:359-369.
70. Teymoortash A, Lippert BM, Werner JA. Steroid hormone receptors in parotid gland cystadenolymphoma (Warthin's tumour). Clin Otolaryngol Allied Sci. 2001;26:411-416.
71. Tojo Y, Bandoh S, Fujita J, et al. A case of synchronous primary lung cancer with hamartoma. Nihon Kokyuki Gakkai Zasshi. 2003;41:474-479.
72. Torikata C, Ishiwata K, Fukai S. Malignant change in a solitary hamartoma of the lung. A case report. Acta Pathol Jpn. 1977;27:541-546.
73. Travis WD, Brambilla E, Muller-Hermelink HK, et al. Tumours of the Lung, Pleura, Thymus and Heart. Lyon: IARC Press; 2004.
74. Tse LL, Finkelstein SD, Siegler RW, et al. Osteoclast-type giant cell neoplasm of salivary gland. A microdissection-based comparative genotyping assay and literature review: extraskeletal "giant cell tumor of bone" or osteoclast-type giant cell "carcinoma"? Am J Surg Pathol. 2004;28:953-961.
75. Umemori Y, Ando A, Okabe K, et al. Clinical analysis of lung cancer in patients with chondromatous hamartoma. Kyobu Geka. 1995;48:1061-1064.
76. Ushiyama T, Ueyama H, Inoue K, et al. Expression of genes for estrogen receptors alpha and beta in human articular chondrocytes. Osteoarthritis Cartilage. 1999;7:560-566.
77. Vadillo-Briceno F, Feder W, Albores-Saavedra J. Malignant mixed tumor of the lung. Chest. 1970;58:84-88.
78. Valimaa H, Savolainen S, Soukka T, et al. Estrogen receptor-beta is the predominant estrogen receptor subtype in human oral epithelium and salivary glands. J Endocrinol. 2004;180:55-62.
79. van den Bosch JM, Wagenaar SS, Corrin B, et al. Mesenchymoma of the lung (so called hamartoma): a review of 154 parenchymal and endobronchial cases. Thorax. 1987;42:790-793.
80. Weber A, Langhanki L, Schutz A, et al. Expression profiles of p53, p63, and p73 in benign salivary gland tumors. Virchows Arch. 2002;441:428-436.
81. Willen R, Uvelius B, Cameron R. Pleomorphic adenoma in the breast of a human female. Aspiration biopsy findings and receptor determinations. Case report. Acta Chir Scand. 1986;152:709-713.
82. Wu CW, Chi CW, Chang TJ, et al. Sex hormone receptors in gastric cancer. Cancer. 1990;65:1396-1400.
83. Zamboni G, Bonetti F, Scarpa A, et al. Expression of progesterone receptors in solid-cystic tumour of the pancreas: a clinicopathological and immunohistochemical study of ten cases. Virchows Archiv. 1993;423:425-431.
84. Zeitlhofer J. Chrondroma (hamartoma) of the lungs. Beitr Pathol Anat. 1954;114:271-284.